Our next era
Meet the new Novartis as we begin our next phase as an innovative medicines company.
How can we improve equity in healthcare?
Beacon of Hope is a partnership to co-create effective, measurable solutions for health equity in the US. Learn more about our recent event in Washington, DC, addressing the systemic nature of the disparities that exist in healthcare today.
Discover our medicines
Our innovative medicines address society’s greatest disease burdens and restore possibility for patients.
Explore our science
Discover how we unravel the mysteries of biology and develop new technologies to fight disease and change lives.
Learn about our impact
Creating a medicine is just the beginning of the journey. Discover how we embrace societal impact as a core business objective.
Latest news
Novartis investigational iptacopan Phase III study demonstrates clinically meaningful and statistically significant proteinuria reduction in patients with C3 glomerulopathy (C3G)
Novartis presents new 48-week results from Phase III APPLY-PNH trial showing sustained efficacy and long-term safety of Fabhalta® (iptacopan) in adults with paroxysmal nocturnal hemoglobinuria (PNH)
Latest Novartis Kisqali® NATALEE analysis reinforces 25% reduction in risk of recurrence across broad population of patients with early breast cancer; supports regulatory submissions
Welcome to where we thrive together
Working together. Learning together. Thriving together. Discover how you can join us in changing people's lives.